CONTROLLED RELEASE FORMULATIONS OF ROPINIROLE

摘要

The present invention relates to non-swelling controlled release dosage forms comprising a therapeutically effective amount of ropinirole or a pharmaceutically acceptable salt thereof and at least one non-swelling release retardant. Further, the non-swelling controlled release dosage forms of the present invention provide effective plasma levels of ropinirole over a period of up to about 24 hours or more after administration.